Single-cell mass cytometry on peripheral cells in Myasthenia Gravis identifies dysregulation of innate immune cells
暂无分享,去创建一个
S. Demeret | E. Fadel | A. Béhin | C. Blanc | S. Berrih-Aknin | J. Guihaire | F. Truffault | R. Le Panse | N. Pinzon | A. Corneau | Odessa-Maud Fayet | J. Verdier | Edouard Hemery
[1] S. Demeret,et al. Central Role of Macrophages and Nucleic Acid Release in Myasthenia Gravis Thymus , 2022, Annals of neurology.
[2] Bin Wang,et al. Abnormal Changes of Monocyte Subsets in Patients With Sjögren’s Syndrome , 2022, Frontiers in Immunology.
[3] F. Ginhoux,et al. Twin study reveals non-heritable immune perturbations in multiple sclerosis , 2022, Nature.
[4] M. Karampetsou,et al. Innate Lymphoid Cells in Autoimmune Diseases , 2022, Frontiers in Immunology.
[5] E. Segura,et al. TLR or NOD receptor signaling skews monocyte fate decision via distinct mechanisms driven by mTOR and miR-155 , 2021, Proceedings of the National Academy of Sciences.
[6] B. Xiao,et al. Single-cell RNA-Seq reveals transcriptional heterogeneity and immune subtypes associated with disease activity in human myasthenia gravis , 2021, Cell discovery.
[7] A. Behren,et al. Targeting butyrophilins for cancer immunotherapy. , 2021, Trends in immunology.
[8] B. Becher,et al. Single-cell profiling of myasthenia gravis identifies a pathogenic T cell signature , 2021, Acta Neuropathologica.
[9] J. Levitt,et al. CD8+CD161+ T-Cells: Cytotoxic Memory Cells With High Therapeutic Potential , 2021, Frontiers in Immunology.
[10] F. Detterbeck,et al. Thymus-derived B cell clones persist in the circulation after thymectomy in myasthenia gravis , 2020, Proceedings of the National Academy of Sciences.
[11] Shaochong Zhang,et al. Genetic landscape and autoimmunity of monocytes in developing Vogt–Koyanagi–Harada disease , 2020, Proceedings of the National Academy of Sciences.
[12] Y. Parman,et al. CD4+ T Cells of Myasthenia Gravis Patients Are Characterized by Increased IL-21, IL-4, and IL-17A Productions and Higher Presence of PD-1 and ICOS , 2020, Frontiers in Immunology.
[13] E. Fadel,et al. Comparative Analysis of Thymic and Blood Treg in Myasthenia Gravis: Thymic Epithelial Cells Contribute to Thymic Immunoregulatory Defects , 2020, Frontiers in Immunology.
[14] A. Amirzargar,et al. IL-27 and autoimmune rheumatologic diseases: The good, the bad, and the ugly. , 2020, International immunopharmacology.
[15] S. Koo,et al. Changes of frequency and expression level of CD161 in CD8+ T cells and natural killer T cells in peripheral blood of patients with systemic lupus erythematosus , 2020, Microbiology and immunology.
[16] P. Carlsson,et al. Mass Cytometry Studies of Patients With Autoimmune Endocrine Diseases Reveal Distinct Disease-Specific Alterations in Immune Cell Subsets , 2020, Frontiers in Immunology.
[17] M. Ciofani,et al. Regulation of γδ T Cell Effector Diversification in the Thymus , 2020, Frontiers in Immunology.
[18] N. McGovern,et al. The human fetal thymus generates invariant effector γδ T cells , 2019, The Journal of experimental medicine.
[19] Jie Zhu,et al. Effects of Follicular Helper T cells and Inflammatory Cytokines on Myasthenia Gravis. , 2019, Current molecular medicine.
[20] F. Ginhoux,et al. Single-Cell Analysis of Human Mononuclear Phagocytes Reveals Subset-Defining Markers and Identifies Circulating Inflammatory Dendritic Cells. , 2019, Immunity.
[21] anonymous,et al. Comprehensive review , 2019 .
[22] V. Martinelli,et al. Loss of Circulating CD8+ CD161high T Cells in Primary Progressive Multiple Sclerosis , 2019, Front. Immunol..
[23] L. Quintana-Murci,et al. A Call for Blood-In Human Immunology. , 2019, Immunity.
[24] Wen-Tao Ma,et al. The Role of Monocytes and Macrophages in Autoimmune Diseases: A Comprehensive Review , 2019, Front. Immunol..
[25] C. Hedrick,et al. Nonclassical Monocytes in Health and Disease. , 2019, Annual review of immunology.
[26] Chuan Wang,et al. Innate, innate-like and adaptive lymphocytes in the pathogenesis of MS and EAE , 2019, Cellular & Molecular Immunology.
[27] Nadine Dragin,et al. Il-23/Th17 cell pathway: A promising target to alleviate thymic inflammation maintenance in myasthenia gravis. , 2019, Journal of autoimmunity.
[28] Huy Q. Dinh,et al. Human Monocyte Heterogeneity as Revealed by High-Dimensional Mass Cytometry , 2019, Arteriosclerosis, thrombosis, and vascular biology.
[29] F. Bolgert,et al. Regulatory B cells in myasthenia gravis are differentially affected by therapies , 2018, Annals of clinical and translational neurology.
[30] Weihui Zhang,et al. Modular bioinformatics analysis demonstrates that a Toll-like receptor signaling pathway is involved in the regulation of macrophage polarization , 2018, Molecular medicine reports.
[31] F. Calzetti,et al. Human dendritic cell subset 4 (DC4) correlates to a subset of CD14dim/-CD16++ monocytes. , 2018, The Journal of allergy and clinical immunology.
[32] I. Prinz,et al. Innately versatile: γδ17 T cells in inflammatory and autoimmune diseases. , 2017, Journal of autoimmunity.
[33] L. Servais,et al. Methylome and transcriptome profiling in Myasthenia Gravis monozygotic twins. , 2017, Journal of autoimmunity.
[34] P. Loke,et al. By CyTOF: Heterogeneity of Human Monocytes. , 2017, Arteriosclerosis, thrombosis, and vascular biology.
[35] Min Zhang,et al. High frequencies of circulating Tfh-Th17 cells in myasthenia gravis patients , 2017, Neurological Sciences.
[36] N. Hacohen,et al. Single-cell RNA-seq reveals new types of human blood dendritic cells, monocytes, and progenitors , 2017, Science.
[37] C. Hedrick,et al. Human Blood Monocyte Subsets: A New Gating Strategy Defined Using Cell Surface Markers Identified by Mass Cytometry , 2017, Arteriosclerosis, thrombosis, and vascular biology.
[38] M. Rojas,et al. Infiltrating CD16+ Are Associated with a Reduction in Peripheral CD14+CD16++ Monocytes and Severe Forms of Lupus Nephritis , 2016, Autoimmune diseases.
[39] F. Shi,et al. Augmentation of Circulating Follicular Helper T Cells and Their Impact on Autoreactive B Cells in Myasthenia Gravis , 2016, The Journal of Immunology.
[40] A. Marx,et al. Randomized Trial of Thymectomy in Myasthenia Gravis. , 2016, The New England journal of medicine.
[41] L. Öhman,et al. Altered expression of Butyrophilin (BTN) and BTN‐like (BTNL) genes in intestinal inflammation and colon cancer , 2016, Immunity, inflammation and disease.
[42] O. Hubscher,et al. Monocytes from Sjögren's syndrome patients display increased vasoactive intestinal peptide receptor 2 expression and impaired apoptotic cell phagocytosis , 2014, Clinical and experimental immunology.
[43] S. Berrih-Aknin,et al. Myasthenia gravis: a comprehensive review of immune dysregulation and etiological mechanisms. , 2014, Journal of autoimmunity.
[44] A. E. Sousa,et al. Human γδ Thymocytes Are Functionally Immature and Differentiate into Cytotoxic Type 1 Effector T Cells upon IL-2/IL-15 Signaling , 2014, The Journal of Immunology.
[45] Sean C. Bendall,et al. Normalization of mass cytometry data with bead standards , 2013, Cytometry. Part A : the journal of the International Society for Analytical Cytology.
[46] E. Fadel,et al. SDF-1/CXCL12 recruits B cells and antigen-presenting cells to the thymus of autoimmune myasthenia gravis patients. , 2013, Immunobiology.
[47] A. Hayday,et al. Interleukin 7 (IL-7) selectively promotes mouse and human IL-17–producing γδ cells , 2012, Proceedings of the National Academy of Sciences.
[48] Sean C. Bendall,et al. A deep profiler's guide to cytometry. , 2012, Trends in immunology.
[49] Nikolaos Scarmeas,et al. The good, bad, and ugly? , 2012, Neurology.
[50] A. Hayday,et al. Butyrophilins: an emerging family of immune regulators. , 2012, Trends in immunology.
[51] J. Casanova,et al. Human CD14dim Monocytes Patrol and Sense Nucleic Acids and Viruses via TLR7 and TLR8 Receptors , 2010, Immunity.
[52] J. Trowsdale,et al. BTN1A1, the Mammary Gland Butyrophilin, and BTN2A2 Are Both Inhibitors of T Cell Activation , 2010, The Journal of Immunology.
[53] Pablo Tamayo,et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[54] A. Saoudi,et al. Functional defect of regulatory CD4(+)CD25+ T cells in the thymus of patients with autoimmune myasthenia gravis. , 2005, Blood.
[55] David Botstein,et al. GO: : TermFinder--open source software for accessing Gene Ontology information and finding significantly enriched Gene Ontology terms associated with a list of genes , 2004, Bioinform..
[56] A. Annoni,et al. Expression of Transforming Growth Factor‐β1 in Thymus of Myasthenia Gravis Patients , 2003 .
[57] A. Annoni,et al. Expression of transforming growth factor-beta1 in thymus of myasthenia gravis patients: correlation with pathological abnormalities. , 2003, Annals of the New York Academy of Sciences.
[58] G. Huberfeld,et al. Validity and reliability of two muscle strength scores commonly used as endpoints in assessing treatment of myasthenia gravis , 2000, Journal of Neurology.
[59] G. Nuki,et al. Evidence for defect of complement-mediated phagocytosis by monocytes from patients with rheumatoid arthritis and cutaneous vasculitis. , 1981, British medical journal.